VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function
Breast cancer stem cells are responsible for cancer initiation, progression, and drug resistance. However, effective targeting strategies against the cell subpopulation are still limited. Here, we unveil two splice variants of very-low-density lipoprotein receptor, VLDLR-I and -II, which are highly...
Main Authors: | Mengying Yang, Yajing Zhan, Zhijie Hou, Chunli Wang, Wenjun Fan, Tao Guo, Zhuoshi Li, Lei Fang, Shasha Lv, Sisi Li, Chundong Gu, Mingliang Ye, Hongqiang Qin, Quentin Liu, Xiaonan Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.887035/full |
Similar Items
-
TGF-β-activated circRYK drives glioblastoma progression by increasing VLDLR mRNA expression and stability in a ceRNA- and RBP-dependent manner
by: Yuhang Wang, et al.
Published: (2024-03-01) -
Effects of the microRNA-99a-5p/VLDLR axis in lung cancer cell sensitivity to chemotherapy and its mechanism
by: Yaoguo Lang, et al.
Published: (2023-11-01) -
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
by: Mohammad Zarei, et al.
Published: (2018) -
VARIATIONS AND EXPRESSION OF VERY LOW-DENSITY LIPOPROTEIN RECEPTOR (VLDLR) mRNA IN THE LIVER AND OVARY OF A LOW EGG PRODUCTION STRAIN OF LOCAL IRAQI HENS
by: D. H. Al-Hassani, et al.
Published: (2023-02-01) -
Analysis of Dormancy-Associated Transcriptional Networks Reveals a Shared Quiescence Signature in Lung and Colorectal Cancer
by: Adriano Cuccu, et al.
Published: (2022-08-01)